Efficacy of caspofungin as salvage therapy for invasive aspergillosis compared to standard therapy in a historical cohort
J. Hiemenz(University of Florida), Thomas J. Walsh(Cornell University), Russell S. Berman(Cornell University), Alfred J. Saah(Merck & Co., Inc., Rahway, NJ, USA (United States)), Issam Raad(Missouri Department of Agriculture), J. Maertens(KU Leuven), Carole A. Sable(United States Military Academy), Thomas F. Patterson(National Institute of Allergy and Infectious Diseases), Mariasavina Severino(United States Military Academy), David W. Denning(Manchester Academic Health Science Centre), Patricia Saddier(United States Military Academy), Desmon̄d Ryan(United States Military Academy), J Chodakewitz(United States Military Academy), Mark J. DiNubile(Io Therapeutics (United States)), Ray Hachem(The University of Texas MD Anderson Cancer Center)
European Journal of Clinical Microbiology & Infectious Diseases
August 11, 2010
Cited by 45
Related Papers
Revised Definitions of Invasive Fungal Disease from the European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/MSG) Consensus Group
|Clinical Infectious Diseases|2008|4.9k
Clinical Practice Guideline for the Management of Candidiasis: 2016 Update by the Infectious Diseases Society of America
|Clinical Infectious Diseases|2015|4k
Clinical Practice Guidelines for the Diagnosis and Management of Intravascular Catheter-Related Infection: 2009 Update by the Infectious Diseases Society of America
|Clinical Infectious Diseases|2009|3.6k
Voriconazole versus Amphotericin B for Primary Therapy of Invasive Aspergillosis
|New England Journal of Medicine|2002|3.3k
Clinical Practice Guidelines for the Management Candidiasis: 2009 Update by the Infectious Diseases Society of America
|Clinical Infectious Diseases|2009|3.2k